Multiple myeloma differential diagnosis: Difference between revisions
Jump to navigation
Jump to search
Shyam Patel (talk | contribs) No edit summary |
Shyam Patel (talk | contribs) No edit summary |
||
Line 52: | Line 52: | ||
*RANK ligand inhibitors (denosumab) | *RANK ligand inhibitors (denosumab) | ||
|- | |- | ||
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold; text-align:center;" |'''[[ | | style="padding: 5px 5px; background: #DCDCDC; font-weight: bold; text-align:center;" |'''[[Osteomalacia]]''' | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* | *Inadequate mineralization of bone | ||
* | *Deficiencies in vitamin D, calcium, or phosphorus | ||
*Renal tubular acidosis | |||
*Malabsorption | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* | *Diffuse [[bone]] pain, fatigue, and [[fractures]] | ||
* | *Low [[bone mineral density|bone mineral density (BMD)]] | ||
*[[Hypocalcemia]] | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* | *Vitamin D3 supplementation | ||
|- | |- | ||
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold; text-align:center;" |'''[[Scurvy]]''' | | style="padding: 5px 5px; background: #DCDCDC; font-weight: bold; text-align:center;" |'''[[Scurvy]]''' | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* | *Vitamin C deficieny | ||
* | *Malabsorption | ||
*Hemodialysis | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* | *Gum disease | ||
* | *Loose teeth | ||
*Easy bruising | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
*Vitamin C supplementation | |||
*Citrus fruits | |||
|- | |- | ||
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold; text-align:center;" |'''[[Osteogenesis imperfecta]]''' | | style="padding: 5px 5px; background: #DCDCDC; font-weight: bold; text-align:center;" |'''[[Osteogenesis imperfecta]]''' | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* | *Mutations in '''COL1A1'' or ''COL1A2'' | ||
*Impaired type I collagen synthesis | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* | *[[Short stature]], [[scoliosis]], and propensity for [[Bone fracture|fractures]] | ||
* | *Blue discoloration of sclera | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
*Bisphosphonates | |||
*Physical therapy | |||
*Surgical fixation of brittle bones | |||
*Genetic counseling for offspring | |||
|- | |- | ||
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold; text-align:center;" |'''[[Homocystinuria]]''' | | style="padding: 5px 5px; background: #DCDCDC; font-weight: bold; text-align:center;" |'''[[Homocystinuria]]''' | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* | *Deficiency of cystathione ''beta'' synthase | ||
*Deficiency of folate, vitamin B12, or vitamin B6 | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
*Diffuse [[bone]] [[pain]] and [[musculoskeletal]] symptoms | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* | *High-dose vitamin B6 supplementation | ||
* | *Betaine supplementation | ||
|} | |} | ||
|} | |} |
Revision as of 02:00, 5 August 2018
Multiple myeloma Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Multiple myeloma differential diagnosis On the Web |
American Roentgen Ray Society Images of Multiple myeloma differential diagnosis |
Risk calculators and risk factors for Multiple myeloma differential diagnosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Haytham Allaham, M.D. [2]
Overview
Multiple myeloma must be differentiated from monoclonal gammopathy of undetermined significance (MGUS), isolated plasmacytoma of the bone, and extramedullary plasmacytoma.[1]
Differentiating Multiple Myeloma from other Diseases
- The table below summarizes how to differentiate multiple myeloma from other conditions that cause similar presentation:[1]
|
References
- ↑ 1.0 1.1 "Myeloma - SEER Stat Fact Sheets". Retrieved 17 February 2014.